Aclaris Therapeutics Inc (ACRS)
1.19
+0.02
(+1.71%)
USD |
NASDAQ |
Apr 25, 16:00
1.195
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Cash from Financing (Quarterly): 0.049M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.049M |
| September 30, 2023 | -0.087M |
| June 30, 2023 | 26.74M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.037M |
| September 30, 2022 | -0.011M |
| June 30, 2022 | 72.81M |
| March 31, 2022 | 0.03M |
| December 31, 2021 | -0.002M |
| September 30, 2021 | -11.57M |
| June 30, 2021 | 135.87M |
| March 31, 2021 | 100.75M |
| December 31, 2020 | 7.829M |
| September 30, 2020 | -0.278M |
| June 30, 2020 | -0.097M |
| March 31, 2020 | 10.92M |
| December 31, 2019 | -30.01M |
| September 30, 2019 | -0.07M |
| Date | Value |
|---|---|
| June 30, 2019 | -0.117M |
| March 31, 2019 | -0.12M |
| December 31, 2018 | 128.18M |
| September 30, 2018 | 0.019M |
| June 30, 2018 | -0.299M |
| March 31, 2018 | 0.358M |
| December 31, 2017 | -0.078M |
| September 30, 2017 | 80.92M |
| June 30, 2017 | 19.34M |
| March 31, 2017 | 0.209M |
| December 31, 2016 | 98.26M |
| September 30, 2016 | 0.013M |
| June 30, 2016 | 18.55M |
| March 31, 2016 | |
| December 31, 2015 | 58.06M |
| September 30, 2015 | 39.25M |
| June 30, 2015 | -0.664M |
| March 31, 2015 | -0.231M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-30.01M
Minimum
Dec 2019
135.87M
Maximum
Jun 2021
16.46M
Average
--
Median
Mar 2023
Cash from Financing (Quarterly) Benchmarks
| Aldeyra Therapeutics Inc | -1.012M |
| Akoya Biosciences Inc | 11.08M |
| MSP Recovery Inc | 13.66M |
| Bullfrog AI Holdings Inc | -0.2133M |
| Cadrenal Therapeutics Inc | -0.0125M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.761M |
| Cash from Investing (Quarterly) | 7.55M |
| Free Cash Flow | -79.63M |
| Free Cash Flow Per Share (Quarterly) | -0.1016 |
| Free Cash Flow to Equity (Quarterly) | -7.202M |
| Free Cash Flow Yield | -95.47% |